ArticleCardiovascular revascularization medicine : including molecular interventions2022

One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape.

Jennifer A Rymer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.